Wave Life Sciences WVE Rest Of World — Deferred Income Tax Expense Benefit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Wave Life Sciences’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's rest of world — deferred income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Wave Life Sciences's rest of world — deferred income tax expense benefit?
- Wave Life Sciences (WVE) reported rest of world — deferred income tax expense benefit of $0 in Q4 2025.
- What does rest of world — deferred income tax expense benefit mean?
- This metric represents the non-cash tax expense or benefit arising from temporary differences between the carrying amounts of assets and liabilities for financial reporting and their tax bases within the 'Rest of World' segment. It provides insight into future tax obligations or potential tax savings that will be realized in subsequent periods. Analysts track this to evaluate the long-term tax implications of the company's international accounting practices and asset management.